- Report
- August 2019
- 42 Pages
Global
€2666EUR$2,995USD£2,307GBP
- Report
- March 2019
- 372 Pages
Global
€19580EUR$22,000USD£16,946GBP
- Report
- February 2019
United States
From €4001EUR$4,495USD£3,462GBP
- Report
- January 2019
- 14 Pages
United Kingdom
From €533EUR$599USD£461GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €19580EUR$22,000USD£16,946GBP
- Report
- November 2018
- 110 Pages
China
From €623EUR$700USD£539GBP
€890EUR$1,000USD£770GBP
- Report
- August 2018
- 10 Pages
United States
From €978EUR$1,099USD£847GBP
- Report
- April 2018
- 79 Pages
Global
From €6675EUR$7,500USD£5,777GBP
- Report
- March 2018
- 99 Pages
Global
From €2448EUR$2,750USD£2,118GBP
- Report
- March 2018
- 159 Pages
Global
From €6675EUR$7,500USD£5,777GBP
- Report
- February 2018
- 680 Pages
Global
From €19580EUR$22,000USD£16,946GBP
- Training
- 60 Minutes
Global
From €133EUR$149USD£115GBP
- Training
- 60 Minutes
Europe
- Training
- 60 Minutes
United States
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more